Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Juan Odendaal invited to training camp in Switzerland
2015-10-19

Juan Odendaal recently in action at the UCI Paralympic World Cup
for road races in Pietermaritzburg.
Photo: Bertus Odendaal

Juan Odendaal from the University of the Free State (UFS) was invited to be part of a training camp in Switzerland, together with some of the world’s leading para-cyclists.

This first-year BA student was recently selected by the cycling body, Union Cyclist International (UCI), to attend the camp which will be held in Aigle from 2-12 November 2015.

Afterwards, Odendaal, who has been the junior South African champion in the C3 division in road races, time trials, and pursuit races, will travel to Manchester, England, where he will compete in a para-cycling event from 13-15 November 2015.

Recently, he took part in the senior division of the UCI Paralympic World Cup for road races for the first time, and has performed well. In this event, which was held in Pietermaritzburg, he competed against participants from countries including Germany, Australia, Spain, and Russia.

Odendaal on 11 September 2015 took eighth place in the road race and tenth place in the time trial. The road race takes place over 55 km and the time trial over 24 km.

Odendaal said he realised immediately that he was competing at senior level.

“There was a marked difference in the quality of the races,” he said, about the World Cup in Pietermaritzburg.

“It was much faster than I had expected. The average speed was 37,2 kilometres per hour.”

Odendaal also made his debut for South Africa in March of this year at the UCI Para-cycling Track World Championships in Apeldoorn, The Netherlands. At this event, he finished in fifteenth place in both the time trials and the pursuit event.

Odendaal said his main goal is the World Championships, which will take place in Montichiari, Italiy, in March 2016. He is hoping to achieve good times there in order to qualify for the 2016 Olympics in Rio de Janeiro.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept